CD163L1 | CD163 molecule-like 1 | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD300LF | CD300 molecule-like family member f | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HIST2H3PS2 | Histone cluster 2, H3, pseudogene 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
HMHA1 | Histocompatibility (minor) HA-1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IGSF21 | Immunoglobin superfamily, member 21 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RB | Interleukin 2 receptor, beta | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYO1F | Myosin IF | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000437563} | Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TBC1D10C | TBC1 domain family, member 10C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
VCAM1 | Vascular cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |